Ψ-2C-DFMO

Ψ-2C-DFMO, also known as ψ-2C-O-35 or as 4-difluoromethoxy-2,6-dimethoxyphenethylamine, is a psychedelic drug of the phenethylamine and ψ-phenethylamine families.^[2][1] It is the phenethylamine (α-demethyl) analogue of ψ-DODFMO and is also structurally related to other psychedelics like difluoromescaline (DFM) and 2C-T-35 (2C-T-DFM).^[2][1] The drug has been found to be active at a dose of 17 mg orally, with moderately intense effects and a relatively long duration of around 18 hours.^[2][1] Ψ-2C-DFMO was first described in the scientific literature by Daniel Trachsel in 2012.^[2][1]

Ψ-2C-DFMO

Clinical data
Other names	ψ-2C-O-35; 4-Difluoromethoxy-2,6-dimethoxyphenethylamine
Routes of administration	Oral[1]
Drug class	Serotonergic psychedelic; Hallucinogen
ATC code	None
Pharmacokinetic data
Duration of action	~18 hours[1]
Identifiers
IUPAC name 2-[4-(difluoromethoxy)-2,6-dimethoxyphenyl]ethan-1-amine
Chemical and physical data
Formula	C11H15F2NO3
Molar mass	247.242 g·mol−1
3D model (JSmol)	Interactive image
SMILES NCCc1c(OC)cc(cc1OC)OC(F)F
InChI InChI=1S/C11H15F2NO3/c1-15-9-5-7(17-11(12)13)6-10(16-2)8(9)3-4-14/h5-6,11H,3-4,14H2,1-2H3 Key:MOGVICJGCUEFKA-UHFFFAOYSA-N

See also

• ψ-Phenethylamine
• ψ-DODFMO
• Difluoromescaline (DFM)
• 2C-T-35 (2C-T-DFM)